Designing Small Molecules to Outsmart Cancer cells

By

Prof. Arindam Mukherjee

Published on
November 15, 2025

Department of Chemical Sciences and Centre for Advanced Functional Materials (CAFM), Indian Institute of Science Education and Research Kolkata, Mohanpur campus, Mohanpur 741246, India

Areas of Expertise
Medicinal Inorganic Chemistry, Photodynamic Therapy, Kinase-Targeted Cancer Drug Design

My research at the Indian Institute of Science Education and Research Kolkata (IISER-K) focuses on developing metal complexes as chemotherapeutic agents against cancer and disseminating their mechanism of action. We design kinetically inert complexes to resist deactivation by cellular thiols, an important limitation of clinical platinum drugs. Our goal is to maximize dose effectiveness while shifting the therapeutic target away from nuclear DNA to minimize mutagenic effects. By incorporating ligands derived from pharmacophores with stand-alone biomolecular activity, we ensure that even dissociated components retain drug-like function. This strategy has yielded promising complexes capable of even killing cancer stem cells. Our work has since expanded to include light-activated photodynamic therapy and proteomics-based studies to map pathway regulation during chemotherapy. A major outcome of this research in collaboration with Dr. B. Kiran Kumar (CCMB, Hyderabad), resulted in the paper “Peroxiredoxin Depletion and Oxidative Stress by Cyclometalated Ir(III)-Isatin Complexes Renders Ferroptosis and Autophagic Cell Death in Triple-Negative Breast Cancer”, highlighted in this issue.

In my humble opinion, a key strategy in next-generation metal-based drug design should be to address the inherent promiscuity of small molecules by making them more target specific, enhancing the target economy of a single small molecule chemotherapeutic agent like a MIRV missile. Exploit the unique nature of metals (diverse oxidation states, coordination geometries, ligand-exchange kinetics) and combine with suitable organic pharmacophores to develop smart metallodrugs that can be target specific in intact form and with specific stimuli break into multiple active components, each capable of acting on distinct biological pathways. Thus, it leads to efficient utilization of a single drug molecule to modulate multiple therapeutic targets (molecular target economy) collectively producing a stronger and improved patient prognosis.

Looking back, I’ve come to realize that understanding the mechanism of action is not just a scientific necessity, it’s the soul of drug discovery. The road ahead may be long and uncertain no doubt, but every challenge you face will teach you something invaluable. Cancer is a remarkably adaptive adversary, constantly finding new ways to survive. Our mission, as researchers, is to design molecules that are just as clever and then a little smarter. Progress may seem slow at times but every small insight, every careful experiment, brings us one step closer to making a real and lasting difference. One should never lose sight of the purpose behind the work.

Science Factors.

Inside a Legume Root Nodule: Building the Network for Nitrogen Fixation and Sustainable Agriculture

Dr. Senjuti Sinharoy
0
What is the importance of nitrogen fixation? Nitrogen is one of the essential nutrients required for plant growth. Although nearly 78% of the Earth's atmosphere...

Beyond Potency: What Defines the Next Generation Selective HDAC8 Inhibitor?

Dr. Kondapalli Venkata Gowri. Chandra Sekhar
0
Histone deacetylases (HDACs) regulate the acetylation state of histone and non-histone proteins and therefore affect transcription, chromatin organization, cell cycle control and various signalling...

Overcoming Chemotherapy Resistance by Targeting Cancer’s Cellular Defences

Dr. N. Rajendra Prasad
0
Why does chemotherapy stop working? One of the greatest challenges in cancer treatment is not simply finding drugs that kill cancer cells, but understanding...

Understanding Antibiotic Resistance Through the Structure and Function of Bacterial Enzymes

Dr. Immanuel Dhanasingh
0
When life-saving medicines stop working Imagine having an infection that was once easily treated with antibiotics, but the same medicines no longer work. This is...

Strengthening Infection Prevention and Responsible Antibiotic Use through Communication and Teamwork

Dr Anup R Warrier
0
Consider a patient recovering after abdominal surgery. On the second postoperative day, a nurse notes that the urinary catheter no longer has a clear...

From engineered tissues to organ-on-a-chip: How bioengineering is transforming biomedical research and regenerative medicine

Prof. Sanjeev Kumar Mahto
0
Biomedical engineering is increasingly at the interface of living and engineered systems. Many biological questions are still difficult to answer using standard two-dimensional (2D)...

Beyond Memory Loss: A Metabolic View of Cognitive Decline and Dementia

Prof. Rameshwar Nath Chaurasia
0
Looking beyond symptoms Memory loss is one of the best-known signs of dementia, but it is only the visible part of a much more complex...

Beneath the Surface: Understanding Rhizosphere Interactions and Plant Development for Sustainable Agriculture

Dr. Mukesh Jain
0
Beneath every plant lies the rhizosphere, the narrow zone of soil surrounding the roots where plants and microbes constantly exchange chemical signals. Plants release...